Exelixis, Inc.EXELNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank36
3Y CAGR+16.8%
5Y CAGR-4.0%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+16.8%/yr
vs -17.4%/yr prior
5Y CAGR
-4.0%/yr
Recent acceleration
Acceleration
+34.2pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthCompressed
PeriodValueYoY Change
20255.10+12.3%
20244.54+8.9%
20234.17+30.3%
20223.20-20.2%
20214.01-36.0%
20206.27+13.7%
20195.51-19.7%
20186.86-65.2%
201719.72+1.1%
201619.51-